Esperion Therapeutics (ESPR) Shares Outstanding (Diluted) (2018 - 2026)
Esperion Therapeutics (ESPR) Shares Outstanding (Diluted) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 9.03 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.40 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 47.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 103.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 506.00 Mn |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn | 251.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251.35 Mn |
| Dec 31, 2025 | 207.87 Mn |
| Sep 30, 2025 | 200.74 Mn |
| Jun 30, 2025 | 197.55 Mn |
| Mar 31, 2025 | 196.13 Mn |
| Dec 31, 2024 | 187.18 Mn |
| Sep 30, 2024 | 194.93 Mn |
| Jun 30, 2024 | 188.79 Mn |
| Mar 31, 2024 | 189.64 Mn |
| Dec 31, 2023 | 103.11 Mn |
| Sep 30, 2023 | 111.87 Mn |
| Jun 30, 2023 | 109.24 Mn |
| Mar 31, 2023 | 78.44 Mn |
| Dec 31, 2022 | 66.41 Mn |
| Sep 30, 2022 | 67.81 Mn |
| Jun 30, 2022 | 63.23 Mn |
| Mar 31, 2022 | 60.95 Mn |
| Dec 31, 2021 | 28.90 Mn |
| Sep 30, 2021 | 26.46 Mn |
| Jun 30, 2021 | 26.23 Mn |